Renaissancere Holdings LTD RNR
We take great care to ensure that the data presented and summarized in this overview for RENAISSANCERE HOLDINGS LTD is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding RNR
View all-
Vanguard Group Inc Valley Forge, PA5.43MShares$1.3 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$1.13 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA2.88MShares$693 Million0.11% of portfolio
-
Orbis Allan Gray LTD Hamilton, D02.86MShares$689 Million4.83% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL2.4MShares$577 Million0.55% of portfolio
-
Boston Partners Boston, MA2.01MShares$484 Million0.65% of portfolio
-
State Street Corp Boston, MA1.97MShares$473 Million0.02% of portfolio
-
Impax Asset Management Group PLC1.88MShares$452 Million2.37% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.82MShares$438 Million0.05% of portfolio
-
American International Group, Inc. New York, NY1.32MShares$318 Million7.96% of portfolio
Latest Institutional Activity in RNR
Top Purchases
Top Sells
About RNR
RenaissanceRe Holdings Ltd. provides reinsurance and insurance products in the United States and internationally. The company operates through Property, and Casualty and Specialty segments. The Property segment writes property catastrophe excess of loss reinsurance and excess of loss retrocessional reinsurance to insure insurance and reinsurance companies against natural and man-made catastrophes, including hurricanes, earthquakes, typhoons, and tsunamis, as well as claims arising from other natural and man-made catastrophes comprising winter storms, freezes, floods, fires, windstorms, tornadoes, explosions, and acts of terrorism; and other property class of products, such as proportional reinsurance, property per risk, property reinsurance, binding facilities, and regional U.S. multi-line reinsurance. The Casualty and Specialty segment writes various classes of products, such as directors and officers, medical malpractice, and professional indemnity; automobile and employer's liability, casualty clash, umbrella or excess casualty, workers' compensation, and general liability; financial and mortgage guaranty, political risk, surety, and trade credit; and accident and health, agriculture, aviation, cyber, energy, marine, satellite, and terrorism. The company distributes its products and services primarily through intermediaries. RenaissanceRe Holdings Ltd. was founded in 1993 and is headquartered in Pembroke, Bermuda.
Insider Transactions at RNR
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 11
2025
|
Robert Qutub EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,719
-4.55%
|
$888,841
$239.41 P/Share
|
Mar 11
2025
|
Robert Qutub EVP, Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,117
-1.35%
|
-
|
Mar 11
2025
|
Ross Curtis EVP,Chief Portfolio Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,246
-0.66%
|
-
|
Mar 11
2025
|
Kevin O Donnell Pres & Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,478
-2.68%
|
$2,743,242
$239.41 P/Share
|
Mar 11
2025
|
Kevin O Donnell Pres & Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,447
-0.8%
|
-
|
Mar 01
2025
|
Ross Curtis EVP,Chief Portfolio Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,439
+2.98%
|
-
|
Mar 01
2025
|
David C Bushnell Director |
BUY
Grant, award, or other acquisition
|
Direct |
694
+3.58%
|
-
|
Mar 01
2025
|
Torsten Jeworrek Director |
BUY
Grant, award, or other acquisition
|
Direct |
694
+23.86%
|
-
|
Mar 01
2025
|
James L Gibbons Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,325
+4.05%
|
-
|
Mar 01
2025
|
Robert Qutub EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,706
-0.51%
|
$404,322
$237.62 P/Share
|
Mar 01
2025
|
Robert Qutub EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,650
+6.06%
|
-
|
Mar 01
2025
|
Loretta J. Mester Director |
BUY
Grant, award, or other acquisition
|
Direct |
694
+35.03%
|
-
|
Mar 01
2025
|
Carol P Sanders Director |
BUY
Grant, award, or other acquisition
|
Direct |
694
+9.43%
|
-
|
Mar 01
2025
|
David E Marra EVP,Chief Underwriting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
831
-0.45%
|
$196,947
$237.62 P/Share
|
Mar 01
2025
|
David E Marra EVP,Chief Underwriting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,202
+7.41%
|
-
|
Mar 01
2025
|
Valerie Rahmani Director |
BUY
Grant, award, or other acquisition
|
Direct |
694
+7.88%
|
-
|
Mar 01
2025
|
Sean G Brosnan SVP, Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,866
+18.74%
|
-
|
Mar 01
2025
|
James Christopher Fraser SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,472
+8.25%
|
-
|
Mar 01
2025
|
Henry Klehm Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
694
+3.4%
|
-
|
Mar 01
2025
|
Shyam H Gidumal Director |
BUY
Grant, award, or other acquisition
|
Direct |
694
+17.68%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 91K shares |
---|
Open market or private sale | 12.7K shares |
---|---|
Sale (or disposition) back to the issuer | 8.15K shares |
Payment of exercise price or tax liability | 39.5K shares |
Bona fide gift | 131 shares |